Why Autodesk Fell Flat in Q2
Autodesk is scheduled to release its fiscal second quarter financial results after the markets closed on Thursday. The firm said that it had $0.65 in earnings per share (EPS) and $796.8 million in revenue,…
All Work
Chris Lange
What to Expect When Tiffany Reports Before Wednesday’s Open
Tiffany is scheduled to release its fiscal second-quarter financial results before the markets open on Wednesday.
Are Price Hikes at Lyft on the Horizon?
A recent analyst report suggests that Lyft could turn a profit sooner than once thought, but there is a tradeoff. Lyft could achieve this but it would have to increase its prices to hit…
Can Papa John’s New CEO Cut It?
Papa John’s shares jumped on Tuesday after the pizza chain provided a huge update to its business. Effective immediately, Rob Lynch will be replacing Steve Ritchie as president and CEO of the company.
Cannabis Stocks See Even Higher Levels of Short Interest
The August 15 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
Short Sellers Hike Their Bets in Biotech
The August 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Big Pharma Sees a Rising Tide in Short Interest
The August 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Short Sellers Run for Cover on Major Semiconductors
The August 15 short interest data have been compared with the previous report. Short interest in most of these selected semiconductor stocks decreased.
Is Amgen Overpaying for Celgene’s Psoriasis Treatment?
Both Amgen and Celgene shares made a handy gain on Monday after it was announced that the companies had made an agreement in relation to Celgene’s merger with Bristol-Myers Squibb.
Can Kraft Heinz Turn Itself Around With New CFO?
Kraft Heinz shares made a slight gain on Monday after the firm announced that it would be bringing back its former chief financial officer to help turn the company around.
How Beyond Meat Is Breaking Into Fried Chicken
Beyond Meat shares jumped on Monday after the company announced that Beyond Fried Chicken would make its debut at KFC in Atlanta on August 27.
Fibrogen Announces Passing of CEO
FibroGen shares dipped slightly on Monday after the firm announced the passing of its CEO Thomas B. Neff over the weekend. An interim CEO has been named.
What This Cholesterol Study Means Going Forward
Medicines Company shares jumped early on Monday after the firm announced results from its late-stage cholesterol study of inclisiran.
Best Buy, Campbell Soup, Costco, Dell, Dollar Tree and More Earnings Coming This Week
24/7 Wall St. has put together a preview of Best Buy, Costco, Dell and some of the other prominent earnings reports expected this week.
Why Wedbush Sees Over 40% Upside at VMware After Acquisitions
Wedbush weighed in on VMware's acquisition spree. The company has announced that it will acquire both Carbon Black and Pivotal Software.
Why Foot Locker Is Kicking Itself After Earnings
Foot Locker shares tanked after the firm reported its most recent quarterly results before the markets opened on Friday. However, this was not the only contributing factor to the drop.
Peppa Pig Finds a New Home at Hasbro
Hasbro shares dipped on Friday after the firm announced that it would be acquiring eOne in an all-cash transaction. Through this acquisition, Hasbro is looking to advance its position as a leading global play…
HP Executive Shakeup Overshadows Earnings Beat
HP released its most recent quarterly results after the markets closed on Thursday, along with a huge update to executive leadership. With all this commotion, investors sent shares lower as a result.
Is Salesforce Back After Q2?
Salesforce released its fiscal second quarter financial results after the markets closed on Thursday. The firm said that it had $0.66 in earnings per share (EPS) and $4.0 billion in revenue, compared with consensus…
Can This Neurodegeneration Study Find a Way Forward?
Retrophin shares hit a multiyear low after the firm announced late-stage results from its study in patients with pantothenate kinase-associated neurodegeneration.